Biodegradable Stents Market Size to Reach USD 639.71 Million by 2033, Driven by Advancements in Card

Author : Sameer Straits2 | Published On : 14 Apr 2026

The global Biodegradable Stents Market is witnessing steady growth, fueled by increasing demand for advanced cardiovascular treatments and the rising prevalence of heart-related disorders worldwide. According to the latest report by Straits Research, the market was valued at USD 419.50 million in 2024 and is expected to grow to USD 439.64 million in 2025, eventually reaching USD 639.71 million by 2033, expanding at a compound annual growth rate (CAGR) of 4.8% during the forecast period.

Biodegradable stents, also known as bioresorbable stents, are revolutionizing the field of interventional cardiology. Unlike traditional metallic stents, these devices gradually dissolve in the body after fulfilling their function, reducing long-term complications such as chronic inflammation and late stent thrombosis. This innovative feature is significantly enhancing patient outcomes and driving adoption among healthcare providers.

For a smaple report, visit:
👉 https://straitsresearch.com/report/biodegradable-stents-market/request-sample

Market Dynamics

The growth of the biodegradable stents market is primarily driven by the increasing incidence of cardiovascular diseases, particularly coronary artery disease and peripheral artery disease. Sedentary lifestyles, unhealthy dietary habits, and aging populations are contributing to the rising burden of heart diseases globally.

Technological advancements in biomaterials and stent design are further accelerating market growth. Manufacturers are focusing on developing next-generation stents with improved radial strength, controlled degradation rates, and enhanced biocompatibility. These innovations are helping to overcome earlier limitations associated with biodegradable stents, such as limited durability and higher costs.

However, the market faces certain challenges, including stringent regulatory requirements and the high cost of biodegradable stents compared to conventional alternatives. Additionally, limited awareness and adoption in developing regions may restrain market growth to some extent.

For more detailed insights, visit:
👉 https://straitsresearch.com/report/biodegradable-stents-market

Market Segmentation

The biodegradable stents market is segmented based on product, application, absorption rate, and end-user.

By product, the market includes polymer-based biodegradable stents, biodegradable stents, and metal-based biodegradable stents. Among these, polymer-based stents are gaining significant traction due to their superior flexibility and controlled absorption characteristics.

In terms of application, the market is divided into coronary artery disease and peripheral artery disease. The coronary artery disease segment holds the largest market share, owing to the high prevalence of coronary conditions and the increasing number of angioplasty procedures performed globally.

Based on absorption rate, the market is categorized into slow, intermediate, and fast absorption rate stents. Intermediate absorption rate stents are widely preferred as they provide an optimal balance between mechanical support and timely degradation.

By end-user, the market is segmented into hospitals and cardiac centers. Hospitals dominate the segment due to the availability of advanced infrastructure and skilled healthcare professionals, while cardiac centers are witnessing growing adoption due to specialized care and increasing patient inflow.

Regional Analysis

Geographically, the biodegradable stents market spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America holds a significant share of the market, driven by advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative medical technologies. Europe follows closely, supported by favorable reimbursement policies and increasing research activities in the field of cardiovascular devices.

The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rising healthcare investments, a growing patient population, and increasing awareness about advanced treatment options are contributing to market expansion in countries such as China, India, and Japan.

Latin America and the Middle East & Africa regions are also experiencing gradual growth, supported by improving healthcare systems and increasing access to advanced medical treatments.

Key Players

The biodegradable stents market is highly competitive, with several key players focusing on innovation and strategic collaborations to strengthen their market presence. Prominent companies operating in the market include Abbott Laboratories, Biotronik, Reva Medical, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Arterius Limited, and OrbusNeich Medical.

These companies are investing heavily in research and development to introduce advanced biodegradable stents with enhanced safety and efficacy profiles. Partnerships, product launches, and regulatory approvals are key strategies adopted by market players to gain a competitive edge.

Conclusion

The global biodegradable stents market is poised for steady growth, driven by increasing cardiovascular disease prevalence, technological advancements, and growing demand for minimally invasive procedures. While challenges such as high costs and regulatory hurdles persist, ongoing innovations and expanding healthcare access are expected to create significant growth opportunities in the coming years.

About Us

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.